TheraCell announces release of TheraFuze DBF Fiber Wrap

The Fiber Wrap is designed to maintain form and integrity when rehydrated and to withstand manipulation by the surgeon.

TheraCell has announced the first surgical case using its TheraFuze DBF Fiber Wrap. According to TheraCell, this is the third new product in the company’s portfolio of procedure-specific fiber graft solutions to be implanted in  the past few weeks.

A company press release states the DBF Fiber Wrap is provided as a lyophilised sheet, comprised of 100% demineralised cortical bone fibres, that may be rehydrated with saline or the patient’s blood or bone marrow, creating a strong yet flexible sheet that can be manipulated by the surgeon.

Theracell claims the first surgical case using this novel procedure-specific product was performed by Neel Anand (Los Angeles, USA), professor of orthopaedic surgery and director, spine trauma, Cedars Sinai Medical Center, and chairman of orthopaedics and spine, minimally invasive spine surgery, DOCS Surgical Hospital. 

According to TheraCell, the case was a revision procedure involving posterolateral fusion at L5-S1 and T11-12. Anand added autograft and TheraFuze FiberForm to the Fiber Wraps, rolled them to contain the graft material, and placed them in the posterolateral gutters.

“I was very impressed by how easily the Fiber Wraps rehydrated and could be rolled up like a burrito,” said Anand. “It was remarkable how well the sheet held the additional graft materials and I came away with a strong sense of confidence that the graft would stay in place.”


Please enter your comment!
Please enter your name here